Detection of glaucoma progression with stratus OCT retinal nerve fiber layer, optic nerve head, and macular thickness measurements

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 12, 2009, Pages 5741-5748

  Medeiros, Felipe A ^a   Zangwill, Linda M ^a   Alencar, Luciana M ^a   Bowd, Christopher ^a   Sample, Pamela A ^a   Susanna, Remo ^a   Weinreb, Robert N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPTIC NERVE; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; PRIORITY JOURNAL; RANDOM COEFFICIENT MODEL; RECEIVER OPERATING CHARACTERISTIC; RETINA; RETINA MACULA LUTEA; RETINAL NERVE FIBER LAYER; SENSITIVITY AND SPECIFICITY; STEREOPHOTOGRAMMETRY; THICKNESS; VISUAL FIELD; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; METHODOLOGY; MIDDLE AGED; NERVE FIBER; OPEN ANGLE GLAUCOMA; OPTIC DISK; PATHOLOGY; RETINA GANGLION CELL;

DISEASE PROGRESSION; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; NERVE FIBERS; OCULAR HYPERTENSION; OPTIC DISK; PERIMETRY; RETINA; RETINAL GANGLION CELLS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL FIELDS;

EID: 73349101874     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3715     Document Type: Article

References (52)

1. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6): 829-830.
2. Miglior S, Zeyen T, Pfeiffer N, et al. Results of the European Glaucoma Prevention Study. Ophthalmology. 2005;112(3):366-375.
3. Quigley HA, Katz J, Derick RJ, et al. An evaluation of optic disc and nerve fiber layer examinations in monitoring progression of early glaucoma damage. Ophthalmology. 1992;99(1):19-28.
4. Sommer A, Katz J, Quigley HA, et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991;109(1):77-83.
5. Medeiros FA, Zangwill LM, Bowd C, et al. Use of progressive glaucomatous optic disk change as the reference standard for evaluation of diagnostic tests in glaucoma. Am J Ophthalmol. 2005;139(6):1010-1018.
6. Medeiros FA, Zangwill LM, Bowd C, et al. Influence of disease severity and optic disc size on the diagnostic performance of imaging instruments in glaucoma. Invest Ophthalmol Vis Sci. 2006;47(3):1008-1015.
7. Schuman JS, Pedut-Kloizman T, Hertzmark E, et al. Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography. Ophthalmology. 1996;103(11):1889-1898.
8. Schuman JS, Hee MR, Puliafito CA, et al. Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol. 1995;113(5):586-596.
9. Bowd C, Weinreb RN, Williams JM, Zangwill LM. The retinal nerve fiber layer thickness in ocular hypertensive, normal, and glauco-matous eyes with optical coherence tomography. Arch Ophthal-mol. 2000;118(1):22-26.
10. Zangwill LM, Bowd C, Berry CC, et al. Discriminating between normal and glaucomatous eyes using the Heidelberg Retina Tomograph, GDx Nerve Fiber Analyzer, and Optical Coherence Tomograph. Arch Ophthalmol. 2001;119(7):985-993.
11. Williams ZY, Schuman JS, Gamell L, et al. Optical coherence tomography measurement of nerve fiber layer thickness and the likelihood of a visual field defect. Am J Ophthalmol. 2002;134(4): 538-546.
12. Bowd C, Zangwill LM, Berry CC, et al. Detecting early glaucoma by assessment of retinal nerve fiber layer thickness and visual function. Invest Ophthalmol Vis Sci. 2001;42(9):1993-2003.
13. Budenz DL, Fredette MJ, Feuer WJ, Anderson DR. Reproducibility of peripapillary retinal nerve fiber thickness measurements with stratus OCT in glaucomatous eyes. Ophthalmology. 2008;115(4): 661-666.e4.
14. Paunescu LA, Schuman JS, Price LL, et al. Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci. 2004;45(6): 1716-1724.
15. Gurses-Ozden R, Teng C, Vessani R, et al. Macular and retinal nerve fiber layer thickness measurement reproducibility using optical coherence tomography (OCT-3). J Glaucoma. 2004;13(3):238-244.
16. DeLeon Ortega JE, Sakata LM, Kakati B, et al. Effect of glaucoma-tous damage on repeatability of confocal scanning laser ophthalmoscope, scanning laser polarimetry, and optical coherence tomography. Invest Ophthalmol Vis Sci. 2007;48(3):1156-1163.
17. Blumenthal EZ, Williams JM, Weinreb RN, et al. Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography. Ophthalmology. 2000;107(12):2278-2282.
18. Medeiros FA, Zangwill LM, Bowd C, Weinreb RN. Comparison of the GDx VCC scanning laser polarimeter, HRT II confocal scanning laser ophthalmoscope, and stratus OCT optical coherence tomograph for the detection of glaucoma. Arch Ophthalmol. 2004; 122(6):827-837.
19. Lu AT, Wang M, Varma R, et al. Combining nerve fiber layer parameters to optimize glaucoma diagnosis with optical coherence tomography. Ophthalmology. 2008;115(8):1352-1357.e1-2.
20. Wollstein G, Schuman JS, Price LL, et al. Optical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma. Arch Ophthalmol. 2005;123(4):464-470.
21. Schuman JS. Spectral domain optical coherence tomography for glaucoma: an AOS thesis. Trans Am Ophthalmol Soc. 2008;106: 426-458.
22. Vizzeri G, Balasubramanian M, Bowd C, et al. Spectral domain-optical coherence tomography to detect localized retinal nerve fiber layer defects in glaucomatous eyes. Opt Express. 2009;17(5): 4004-4018.
23. Horn FK, Mardin CY, Laemmer R, et al. Correlation between Local glaucomatous visual field defects and loss of nerve fiber layer thickness measured with scanning laser polarimetry and spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2009;50(5):1971-1977.
24. van Velthoven ME, Faber DJ, Verbraak FD, et al. Recent developments in optical coherence tomography for imaging the retina. Prog Retin Eye Res. 2007;26(1):57-77.
25. Schuman JS, Wollstein G, Farra T, et al. Comparison of optic nerve head measurements obtained by optical coherence tomography and confocal scanning laser ophthalmoscopy. Am J Ophthalmol. 2003;135(4):504-512.
26. Hoffmann EM, Bowd C, Medeiros FA, et al. Agreement among 3 optical imaging methods for the assessment of optic disc topography. Ophthalmology. 2005;112(12):2149-2156.
27. Lin D, Leung CK, Weinreb RN, et al. Longitudinal evaluation of optic disc measurement variability with optical coherence tomography and confocal scanning laser ophthalmoscopy. J Glaucoma. 2009;18(2):101-106.
28. Leung CK, Cheung CY, Lin D, et al. Longitudinal variability of optic disc and retinal nerve fiber layer measurements. Invest Ophthal-mol Vis Sci. 2008;49(11):4886-4892.
29. Medeiros FA, Zangwill LM, Bowd C, et al. Evaluation of retinal nerve fiber layer, optic nerve head, and macular thickness measurements for glaucoma detection using optical coherence tomography. Am J Ophthalmol. 2005;139(1):44-55.
30. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121(1):48-56.
31. Medeiros FA, Alencar LM, Zangwill LM, et al. Detection of progressive retinal nerve fiber layer loss in glaucoma using scanning laser polarimetry with variable corneal compensation. Invest Ophthal-mol Vis Sci. 2009;50(4):1675-1681.
32. Cnaan A, Laird NM, Slasor P. Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med. 1997;16(20):2349-2380.
33. Feldman HA. Families of lines: random effects in linear regression analysis. J Appl Physiol. 1988;64(4):1721-1732.
34. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837-845.
35. Kanamori A, Nakamura M, Escano MF, et al. Evaluation of the glaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence tomography. Am J Ophthalmol. 2003; 135(4):513-520.
36. Parikh RS, Parikh S, Sekhar GC, et al. Diagnostic capability of optical coherence tomography (Stratus OCT 3) in early glaucoma. Ophthalmology. 2007;114(12):2238-2243.
37. Gabriele ML, Ishikawa H, Wollstein G, et al. Optical coherence tomography scan circle location and mean retinal nerve fiber layer measurement variability. Invest Ophthalmol Vis Sci. 2008;49(6): 2315-2321.
38. Vizzeri G, Bowd C, Medeiros FA, et al. Effect of improper scan alignment on retinal nerve fiber layer thickness measurements using Stratus optical coherence tomograph. J Glaucoma. 2008; 17(5):341-349.
39. Ishikawa H, Gabriele ML, Wollstein G, et al. Retinal nerve fiber layer assessment using optical coherence tomography with active optic nerve head tracking. Invest Ophthalmol Vis Sci. 2006;47(3): 964-967.
40. Vizzeri G, Bowd C, Medeiros FA, et al. Scan tracking coordinates for improved centering of Stratus OCT scan pattern. J Glaucoma. 2009;18(1):81-87.
41. Gonzalez-Garcia AO, Vizzeri G, Bowd C, et al. Reproducibility of RTVue retinal nerve fiber layer thickness and optic disc measurements and agreement with stratus optical coherence tomography measurements. Am J Ophthalmol. 2009;147(6):1067-1074.
42. Menke MN, Knecht P, Sturm V, et al. Reproducibility of nerve fiber layer thickness measurements using 3D Fourier-domain OCT. Invest Ophthalmol Vis Sci. 2008;49(12):5386-5391.
43. Giovannini A, Amato G, Mariotti C. The macular thickness and volume in glaucoma: an analysis in normal and glaucomatous eyes using OCT. Acta Ophthalmol Scand Suppl. 2002;236:34-36.
44. Lederer DE, Schuman JS, Hertzmark E, et al. Analysis of macular volume in normal and glaucomatous eyes using optical coherence tomography. Am J Ophthalmol. 2003;135(6):838-843.
45. Greenfield DS, Bagga H, Knighton RW. Macular thickness changes in glaucomatous optic neuropathy detected using optical coherence tomography. Arch Ophthalmol. 2003;121(1):41-46.
46. Guedes V, Schuman JS, Hertzmark E, et al. Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes. Ophthalmology. 2003;110(1):177-189.
47. Wollstein G, Ishikawa H, Wang J, et al. Comparison of three optical coherence tomography scanning areas for detection of glaucomatous damage. Am J Ophthalmol. 2005;139(1):39-43.
48. Legarreta JE, Gregori G, Punjabi OS, et al. Macular thickness measurements in normal eyes using spectral domain optical coherence tomography. Ophthalmic Surg Lasers Imaging. 2008;39(suppl 4):S43-S49.
49. Parrish RK, Schiffman JC, Feuer WJ, et al. Test-retest repro-ducibility of optic disk deterioration detected from stereophoto-graphs by masked graders. Am J Ophthalmol. 2005;140(4):762-764.
50. Jampel HD, Friedman D, Quigley H, et al. Agreement among glaucoma specialists in assessing progressive disc changes from photographs in open-angle glaucoma patients. Am J Ophthalmol. 2009;147(1):39-44.e1.
51. Heijl A, Bengtsson B, Chauhan BC, et al. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients. Ophthalmology. 2008;115(9):1557-1565.
52. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6): 829-830.